ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer

Emma O’Dowd, David Baldwin(University of Nottingham), Wouter H. van Geffen(Radboud University Nijmegen), Ilona Tietzova(Charles University), Rozemarijn Vliegenthart(University Medical Center Groningen), Helmut Prosch(Medical University of Vienna), Nuria Novoa(Bristol-Myers Squibb (Germany)), Sabine Weckbach(Heidelberg University), Hans‐Ulrich Kauczor(Heidelberg University), Marie‐Pierre Revel(Hôpital Européen Georges-Pompidou), Janette Rawlinson(Hôpital Cochin), Mina Gaga(Hygeia Hospital), Mathias Prokop(Radboud University Nijmegen), Aurélie Fabre(St. Vincent's University Hospital), Matthew Donoghue(Galway Clinic), Blin Nagavci(European Society of Clinical Microbiology and Infectious Diseases), Annemiek Snoeckx(University Medical Center Utrecht), Herbert Decaluwé(VIB-KU Leuven Center for Cancer Biology), Joanna Chorostowska‐Wynimko(Unknown), Torsten Blum(MSB Medical School Berlin), Walter De Wever(KU Leuven), Ursula Nestle(University Medical Center Freiburg), Alessandro Brunelli(St James's University Hospital), Jan P. van Meerbeeck(Antwerp University Hospital), Emily Bartlett(Royal Brompton & Harefield NHS Foundation Trust), Anna Kerpel-Fronius(Országos Korányi Tbc és Pulmonológiai Intézet), Giulia Veronesi(Vita-Salute San Raffaele University), Marco Brambilla(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Anand Devaraj(Harefield Hospital), Jürgen Biederer(Heidelberg University), Georgia Hardavella(Sotiria General Hospital), Dirk De Ruysscher(Maastricht University Medical Centre), Paul Martin Putora(University of St. Gallen)
European Respiratory Journal
October 1, 2023
Cited by 44


Related Papers